AseptiQuik G Genderless AQG17004HT
1/4 Hose Barb Genderless AseptiQuik G Connector Body - High Temperature
Polycarbonate, USP Class VI, ADCF
Up to 60 psi, 4.1 bar for 30 days; Up to 75 psi, 5.1 bar for 48 hours
White with white pull tab
34ºF - 104ºF (1ºC - 40ºC)
Silicone, platinum-cured, USP Class VI, ADCF
AseptiQuik G Connectors provide quick and easy sterile connections, even in non-sterile environmentsÑa critical capability for biopharmaceutical manufacturers. Featuring an easy to use three step design and a wide range of optionsÑincluding 1/8- to 1 1/2 -inch sizes and genderless connectionsÑthe AseptiQuik family allows you to transfer media easily with less risk of error. Their robust, reliable performance eliminates the need for clamps, fixtures or tube welders, giving you sterile, high quality single-use connections every time.
At Liquidyne, we prioritize our commitment to quality and consistency. In 2017 we achieved ISO 9001:2015 Quality Management System certification to ensure we can repeatedly deliver consistently high-quality products and solutions. Being an ISO 9001 facility, together with our USP Class VI Testing, ASME Bioprocessing Equipment (BPE), and EHEDG certification guarantee, we have the methodologies to assure quality. We will quickly and accurately rectify any issues if any of our products are ever in non-conformance.
"Thanks so much! What a quick turn around. It is a pleasure working with Liquidyne."
Process Development Manager
"I received the cart yesterday, thanks for the fast delivery! It feels sturdy. I sat on it. It does not bounce. It is also easy to clean and wipe or wash down."
Vice President, Analytical Development and Manufacturing
"Thanks again for reacting so quickly and meeting me halfway with the element. We will be able to get installed and have things keep moving overnight with the night crew. The little things like this are always greatly appreciated when working with Liquidyne."
“This pump cut our processing time from 3 days to 1 shift. I’m not giving this pump back. You will have to come and get it if you want it... and that won’t likely happen.”
VP Antibody Manufacturing